Ascidian Therapeutics
Anika Pavis has over nine years of work experience. Anika began their career in 2011 as a Research Intern at UMass Medical School. Anika then moved to Weill Cornell Medical College in 2014 as a Research Technician II. In 2015, they joined Columbia University Medical Center as a Laboratory Coordinator, and later became a Senior Laboratory Coordinator. In 2020, they joined Ascidian Therapeutics as a Senior Associate Scientist and was promoted to Principal Associate Scientist.
Anika Pavis attended Worcester Polytechnic Institute from 2008 to 2012, where they earned a Bachelor of Science in Biochemistry and Humanities and Arts - Drama/Theatre. Anika then attended Columbia University from 2018 to 2020, where they earned a Master of Science in Biomedical Engineering. Anika also holds a Clinical Laboratory Technologist Restricted License in Molecular Diagnosis from the New York State.
Ascidian Therapeutics
2 followers
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.